Literature DB >> 11095870

Molecular Aspects of Myocarditis.

.   

Abstract

Myocarditis is an acquired form inflammatory heart muscle disease, manifested as acute and chronic conditions. While many etiologies have been reported, the most common cause of this disease is infection, primarily viral. Typically, the specific causative agent(s) and mechanism(s) are elusive. Over the past several years, various new findings have added to our understanding of myocarditis. These include the identification of adenoviruses as important causative agents, a new receptor protein likely to play an important role in the virulence of certain agents affecting the myocardium, and the effect of viruses on the cardiac cytoskeleton. This report reviews the current understanding of myocarditis, proposes a hypothesis about the long-term sequelae, and suggests possible new therapeutic strategies.

Entities:  

Year:  2000        PMID: 11095870     DOI: 10.1007/s11908-000-0008-x

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  56 in total

1.  Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis.

Authors:  S Pankuweit; I Portig; F Lottspeich; B Maisch
Journal:  J Mol Cell Cardiol       Date:  1997-01       Impact factor: 5.000

2.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

3.  Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.

Authors:  H Zhang; P Morgan-Capner; N Latif; Y A Pandolfino; W Fan; M J Dunn; L C Archard
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

4.  iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1.

Authors:  K Bachmaier; N Neu; C Pummerer; G S Duncan; T W Mak; T Matsuyama; J M Penninger
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

5.  Treatment of experimental viral myocarditis with interleukin-10.

Authors:  R Nishio; A Matsumori; T Shioi; H Ishida; S Sasayama
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

6.  Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy.

Authors:  A L Caforio; M Grazzini; J M Mann; P J Keeling; G F Bottazzo; W J McKenna; S Schiaffino
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

7.  Gamma-globulin treatment of acute myocarditis in the pediatric population.

Authors:  N A Drucker; S D Colan; A B Lewis; A S Beiser; D L Wessel; M Takahashi; A L Baker; A R Perez-Atayde; J W Newburger
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

8.  X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus.

Authors:  J A Towbin; J F Hejtmancik; P Brink; B Gelb; X M Zhu; J S Chamberlain; E R McCabe; M Swift
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

9.  Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis.

Authors:  L H Chow; S J Radio; T D Sears; B M McManus
Journal:  J Am Coll Cardiol       Date:  1989-10       Impact factor: 24.094

10.  Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.

Authors:  A J de Belder; M W Radomski; H J Why; P J Richardson; J F Martin
Journal:  Br Heart J       Date:  1995-10
View more
  4 in total

Review 1.  Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.

Authors:  W Poller; U Kühl; C Tschoepe; M Pauschinger; H Fechner; H-P Schultheiss
Journal:  J Mol Med (Berl)       Date:  2005-06-02       Impact factor: 4.599

2.  Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d.

Authors:  Sally A Huber
Journal:  Med Microbiol Immunol       Date:  2004-04-24       Impact factor: 3.402

3.  Coxsackievirus B3-induced myocarditis: infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells.

Authors:  S A Huber
Journal:  Virology       Date:  2008-06-30       Impact factor: 3.616

4.  c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.

Authors:  Iwona A Buskiewicz; Andreas Koenig; Brian Roberts; Jennifer Russell; Cuixia Shi; Sun-Hwa Lee; Jae U Jung; Sally A Huber; Ralph C Budd
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.